Incidencia de sepsis precoz por Streptococcus agalactiae en recién nacidos del Centro Hospitalario Pereira Rossell en el período 2007-2015

Herrera, Tamara I; Murillo, Micaela; Gesuele, Juan Pablo; Moraes, Mario; Mota, María Inés; Gutiérrez, Claudia; Varela, Adriana; Algorta, Gabriela.
Rev. chil. infectol ; 35(4): 424-430, ago. 2018. tab, graf
Artículo en Español | LILACS | ID: biblio-978054

Documentos relacionados

  1. Women's knowledge of and attitudes towards group B streptococcus (GBS) testing in pregnancy: a qualitative study.
  2. A Recombinant Alpha-Like Protein Subunit Vaccine (GBS-NN) Provides Protection in Murine Models of Group B Streptococcus Infection.
  3. A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women.
  4. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention.
  5. Throwing the spotlight on group B streptococcal early onset sepsis prevention: the importance of appropriate second-line antimicrobials.
  6. Toward the prevention of group B streptococcal early onset sepsis: the importance of defining target populations and second-line antimicrobials in line with current guideline recommendations.
  7. Intrapartum antibiotic prophylaxis for women who are screened positive for group B streptococcal colonisation: Clinical compliance with the guideline.
  8. Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study.
  9. Evaluation of appropriate vancomycin prescribing for the prevention of newborn group B streptococcal infections in a community hospital obstetrics service.
  10. The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes.